Lewis Chew - Aug 17, 2021 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Signature
/s/ Daniel Rodriguez, Attorney-in-Fact for Lewis Chew
Stock symbol
DLB
Transactions as of
Aug 17, 2021
Transactions value $
-$2,003,029
Form type
4
Date filed
8/18/2021, 06:21 PM
Previous filing
Aug 9, 2021
Next filing
Aug 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Options Exercise $995K +30K +28.41% $33.15 136K Aug 17, 2021 Direct F1
transaction DLB Class A Common Stock Sale -$285K -2.8K -2.06% $101.68 133K Aug 17, 2021 Direct F1, F2
transaction DLB Class A Common Stock Sale -$494K -4.9K -3.69% $100.82 128K Aug 17, 2021 Direct F1, F3
transaction DLB Class A Common Stock Sale -$1.48M -14.9K -11.63% $99.65 113K Aug 17, 2021 Direct F1, F4
transaction DLB Class A Common Stock Sale -$737K -7.43K -6.57% $99.20 106K Aug 17, 2021 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DLB Employee Stock Option (right to buy) Options Exercise $0 -30K -73.85% $0.00 10.6K Aug 17, 2021 Class A Common Stock 30K $33.15 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest.
F2 The shares were sold in multiple transactions at prices ranging from $101.37 to $102.35, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 The shares were sold in multiple transactions at prices ranging from $100.36 to $101.29, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F4 The shares were sold in multiple transactions at prices ranging from $99.31 to $100.29, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F5 This transaction was executed in multiple trades at prices ranging from $99.15 to $99.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F6 This performance-based stock option award was granted for a total of 32,500 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 125% of target, or 40,625 shares.